Evidence map›Paper›PMID 38257880›Full record

ArticleMicroorganisms2023

Role of the Bacterial Amyloid-like Hfq in Fluoroquinolone Fluxes.

Florian Turbant, Emeline Esnouf, Francois Rosaz, Frank Wien, Grzegorz Węgrzyn, Hugo Chauvet, Véronique Arluison

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Florian TurbantSynchrotron SOLEIL, L'Orme des Merisiers, Saint Aubin BP48, 91192 Gif-sur-Yvette, France.
Emeline EsnoufLaboratoire Léon Brillouin LLB, UMR12 CEA CNRS, CEA Saclay, 91191 Gif-sur-Yvette, France.
Francois RosazLaboratoire Léon Brillouin LLB, UMR12 CEA CNRS, CEA Saclay, 91191 Gif-sur-Yvette, France.
Frank WienSynchrotron SOLEIL, L'Orme des Merisiers, Saint Aubin BP48, 91192 Gif-sur-Yvette, France.ORCID 0000-0002-0752-8735
Grzegorz WęgrzynDepartment of Molecular Biology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0003-4042-7466
Hugo ChauvetSynchrotron SOLEIL, L'Orme des Merisiers, Saint Aubin BP48, 91192 Gif-sur-Yvette, France.
Véronique ArluisonLaboratoire Léon Brillouin LLB, UMR12 CEA CNRS, CEA Saclay, 91191 Gif-sur-Yvette, France.ORCID 0000-0003-4056-7282
Centre National de la Recherche Scientifique · FRSynchrotron soleil · FRUniversity of Gdańsk · PL

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0003-02Agence Nationale de la Recherche IdEx Université Paris Cité ANR-18-IDEX-0001National Science Center Poland 2016/21/N/NZ1/02850synchrotron SOLEIL NAUniversity of Gdansk task grant no. 531-D020-D242-23
6 · The paper itself

Abstract

Due to their two-cell membranes, Gram-negative bacteria are particularly resistant to antibiotics. Recent investigations aimed at exploring new target proteins involved in Gram-negative bacteria adaptation helped to identify environmental changes encountered during infection. One of the most promising approaches in finding novel targets for antibacterial drugs consists of blocking noncoding RNA-based regulation using the protein cofactor, Hfq. Although Hfq is important in many bacterial pathogens, its involvement in antibiotics response is still unclear. Indeed, Hfq may mediate drug resistance by regulating the major efflux system in

Indexed as

AcrAB-TolC drug efflux complexantibiotic import and exportciprofloxacinfluoroquinoloneHfq proteinouter membrane porinriboregulationsingle cellsmall noncoding RNA

Identifiers

PMID38257880
PMCPMC10819720
OpenAlexW4390338931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.